DUBLIN, Ireland, July 19, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue a press release detailing its second quarter 2013 financial results after the market close on Wednesday, July 24, 2013.
Although the Company will not be hosting a quarterly conference call, investors and other interested parties may access the press release by visiting http://ir.wcrx.com and clicking on Press Releases.
The CompanyWarner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the branded pharmaceuticals market, primarily in North America. We are a fully integrated company with internal resources dedicated to the development, manufacture and promotion of our products. WCRX-F
CONTACT: Rochelle Fuhrmann Senior Vice President, Finance 973-442-3281 email@example.com Kevin Crissey Director, Investor Relations 973-907-7084 Kevin.Crissey@wcrx.com
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts